Literature DB >> 11772021

E. coli MEP synthase: steady-state kinetic analysis and substrate binding.

Andrew T Koppisch1, David T Fox, Brian S J Blagg, C D Poulter.   

Abstract

2-C-Methyl-D-erythritol-4-phosphate synthase (MEP synthase) catalyzes the rearrangement/reduction of 1-D-deoxyxylulose-5-phosphate (DXP) to methylerythritol-4-phosphate (MEP) as the first pathway-specific reaction in the MEP biosynthetic pathway to isoprenoids. Recombinant E. coli MEP was purified by chromatography on DE-52 and phenyl-Sepharose, and its steady-state kinetic constants were determined: k(cat) = 116 +/- 8 s(-1), K(M)(DXP) = 115 +/- 25 microM, and K(M)(NADPH) = 0.5 +/- 0.2 microM. The rearrangement/reduction is reversible; K(eq) = 45 +/- 6 for DXP and MEP at 150 microM NADPH. The mechanism for substrate binding was examined using fosmidomycin and dihydro-NADPH as dead-end inhibitors. Dihydro-NADPH gave a competitive pattern against NADPH and a noncompetitive pattern against DXP. Fosmidomycin was an uncompetitive inhibitor against NADPH and gave a pattern representative of slow, tight-binding competitive inhibition against DXP. These results are consistent with an ordered mechanism where NADPH binds before DXP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772021     DOI: 10.1021/bi0118207

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  Terpene Specialized Metabolism in Arabidopsis thaliana.

Authors:  Dorothea Tholl; Sungbeom Lee
Journal:  Arabidopsis Book       Date:  2011-04-06

2.  A closer look at the spectroscopic properties of possible reaction intermediates in wild-type and mutant (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase.

Authors:  Weiya Xu; Nicholas S Lees; Dominique Hall; Dhanushi Welideniya; Brian M Hoffman; Evert C Duin
Journal:  Biochemistry       Date:  2012-06-07       Impact factor: 3.162

3.  A whole-cell phenotypic screening platform for identifying methylerythritol phosphate pathway-selective inhibitors as novel antibacterial agents.

Authors:  Charles A Testa; L Jeffrey Johnson
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

4.  1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.

Authors:  Rakesh K Dhiman; Merrill L Schaeffer; Ann Marie Bailey; Charles A Testa; Hataichanok Scherman; Dean C Crick
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 5.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

Review 6.  Mechanistic aspects of carotenoid biosynthesis.

Authors:  Alexander R Moise; Salim Al-Babili; Eleanore T Wurtzel
Journal:  Chem Rev       Date:  2013-10-31       Impact factor: 60.622

Review 7.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

Review 8.  Fosmidomycin for the treatment of malaria.

Authors:  Jochen Wiesner; Steffen Borrmann; Hassan Jomaa
Journal:  Parasitol Res       Date:  2002-11-30       Impact factor: 2.289

9.  Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.

Authors:  Ann M Guggisberg; Sesh A Sundararaman; Miguel Lanaspa; Cinta Moraleda; Raquel González; Alfredo Mayor; Pau Cisteró; David Hutchinson; Peter G Kremsner; Beatrice H Hahn; Quique Bassat; Audrey R Odom
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

10.  Kinetic characterization and phosphoregulation of the Francisella tularensis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase).

Authors:  Safdar Jawaid; Heather Seidle; Weidong Zhou; Hafsa Abdirahman; Maher Abadeer; Joseph H Hix; Monique L van Hoek; Robin D Couch
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.